Prevalence and outcome of central nervous system (CNS) relapse after allogeneic stem cell transplantation (HSCT) in patients suffering from acute myeloid leukaemia (AML) and acute lymphoblastic leukaemia (ALL) Group Acute Leukemia Working Party (ALWP) Principal investigator Sabine BLUM , Yves Chalandon
Efficacy and Toxicity of ponatinib and 2nd generation TKI given after allogeneic SCT in Ph+ adult ALL. Group Acute Leukemia Working Party (ALWP) Principal investigator Klaus HIRSCHBUEHL
HSCT experience in patients with Interferon gamma receptor deficiencies Diseases Group Inborn Errors Working Party (IEWP) Type of transplant Principal investigator Peter Olbrich
Outcomes of patients treated with Ibrutinib post autologous stem cell transplant for mantle cell lymphoma. Group Lymphoma Working Party (LWP) Principal investigator Steve Robinson / Claire Burney
Non-interventional prospective study on punctual occlusion for the treatment of dry eyes after allo-tx Group Chronic Malignancies Working Party (CMWP) Type of transplant Principal investigator Michel van Gelder
Non-interventional prospective study on metabolic syndrome after HSCT Group Transplant Complications Working Party (TCWP) Type of transplant Principal investigator John Snowden
Data quality check in allogeneic CLL Group Chronic Malignancies Working Party (CMWP) Type of transplant Principal investigator Johannes Schetelig
Analysis of alloSCT in MDS and 5q-chromosomal abnormalities Group Chronic Malignancies Working Party (CMWP) Type of transplant Principal investigator Laurent Garderet
MDS after SAA (cooperation with SAA registry) Group Severe Aplastic Anaemia Working Party (SAAWP) Chronic Malignancies Working Party (CMWP) Type of transplant Principal investigator Jacob Passweg
RATG: Prospective Phase II Pilot study of Rabbit Antithymocyte globulin (ATG, Thymoglobuline®, Genzyme) with Ciclosporin for Patients with Acquired Aplastic Anaemia and comparison with matched historical patients treated with horse ATG and Ciclosporin Group Severe Aplastic Anaemia Working Party (SAAWP) Type of transplant Principal investigator Judith Marsh
Elderly AML: A randomised Phase III study comparing conventional chemotherapy to low dose total body irradiation-based conditioning and hematopoietic stem cell transplantation from related and unrelated donors as consolidation therapy for older patients with AML in 1st complete remission Group Acute Leukemia Working Party (ALWP) Type of transplant Principal investigator Dietger Niederwieser
Non-interventional prospective study on topical tacrolimus for chronic cutaneous GvHD Group Chronic Malignancies Working Party (CMWP) Type of transplant Principal investigator Gregorz Basak